Webcast: Biosimilars: Friend or Foe to Healthcare?
Understanding the opportunities for biosimilars and the threats to innovator biologics
Referencing recent findings from our Therapy Watch syndicated study in RA, this webinar investigates physicians' perceptions of the biosimilars market. Therapy Watch Director Allison Fleetwood and Access Partnership Director Shrinivas Rao Mukku interview a major US payer, who offers expert opinion on the opportunities for biosimilars in the US market, the possible threats to originator brands, and consider what companies entering the market need to do to effectively launch their follow-on biologic.
EULAR Annual European Congress of Rheumatology 2014
Join us at EULAR Congress 2014 in Paris on Friday 13th June at 11:45 - 13:30
We are delighted to be attending and presenting at this year’s EULAR Annual European Congress of Rheumatology in Paris. The EULAR annual congress is a major event in the field of rheumatology and a great forum for scientific (both clinical and basic) educational and social exchange between healthcare professionals involved in rheumatology, patient organisations and the pharmaceutical industry. Representing the Research Partnership and more specifically, Therapy Watch, will be Director Allison Fleetwood and Associate Director Laurent Chanroux who work at our London headquarters.
"I just wanted to extend our thanks for an excellent job..."
"I just wanted to extend our thanks for an excellent job. Despite some challenging fieldwork issues last week and with only 2 working days to turnaround results, you delivered some excellent outputs which will us to move forward clearly with the product campaign."
Commercial Analysis Manager
Huge Untapped Growth Potential of ASEAN
Published in eyeforpharma 2 May 2014 by Marc Yates
In my last column, I discussed the current opportunities for healthcare in the world’s emerging market economies. In this two-part column, I look at the opportunities for pharma in ASEAN, one of the world’s largest and most important economic regions.
"The team did an excellent job designing, executing, and synthesizing the data & insights from this study..."
"The team did an excellent job designing, executing, and synthesizing the data & insights from this study. It was a challenging project involving a large number of countries and in the end the team put together very thorough reports and a concise summary. The input during the design of the quant survey was also very valuable and ensured the right type of data was collected."
Director, Commercial Planning & Operations